XML 24 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash Flows From Operating Activities:      
Net income $ 32,743 $ 40,081 $ 33,719
Adjustments to reconcile net income to net cash provided by operations:      
Provision for loan losses 15,354 6,024 6,072
Depreciation and amortization of premises and equipment, operating leases assets, core deposit intangible, and mortgage servicing rights 6,082 5,963 4,811
Amortization and accretion of securities premiums and discounts, deferred loan fees and costs, net yield and credit mark on acquired loans, and unearned income (1,955) (870) (537)
Amortization and accretion of deferred PPP processing fees (5,140) 0 0
Deferred taxes 1,390 (204) (1,076)
Net realized gains on sales of available-for-sale securities (2,190) (148) 0
Net realized and unrealized losses (gains) on trading securities (328) (1,888) 451
Proceeds from sale of Visa Class B shares 0 463 0
Gain on sale of Visa Class B shares 0 (463) 0
Gain on sale of loans (2,961) (990) (624)
Net losses (gains) on dispositions of premises and equipment and foreclosed assets 1,097 (377) 47
Proceeds from sale of loans 82,619 43,198 23,311
Origination of loans held for sale (87,528) (43,458) (22,990)
Income on bank owned life insurance, including death benefit of proceeds in excess of cash surrender value (1,747) (1,317) (1,408)
Stock-based compensation expense 1,410 1,346 1,545
Changes in:      
Accrued interest receivable and other assets (6,242) 1,072 (3,079)
Accrued interest payable, lease liabilities, and other liabilities (3,846) 3,610 4,613
Net Cash Provided By Operating Activities 28,758 52,042 44,855
Cash Flows from Investing Activities:      
Proceeds from maturities, prepayments and calls of available-for-sale securities 164,488 98,274 76,349
Proceeds from sales of available-for-sale securities 57,185 11,403 0
Proceeds from sale of trading securities 5,935 301 455
Purchase of available-for-sale securities (224,080) (122,358) (189,374)
Purchase of trading securities (2,447) (436) (1,542)
Loan origination and payments, net (244,903) (335,965) (333,552)
Purchase of bank owned life insurance 0 (8,778) 0
Net cash from business combinations 72,852 0 0
Repayment (purchase) of FHLB and other equity interests 7,268 (3,360) (2,991)
Purchase of premises and equipment (5,644) (9,045) (3,068)
Proceeds from the sale of premises and equipment and foreclosed assets 666 1,228 1,048
Net Cash Used In Investing Activities (168,680) (368,736) (452,675)
Net change in:      
Checking, money market and savings accounts 702,452 459,162 412,505
Certificates of deposit (42,510) 32,379 30,466
Deposits held for sale 0 0 0
Purchase of treasury stock (1,307) (1,291) (2,454)
Proceeds from stock offering, net of issuance costs 3,257 1,423 0
Proceeds from preferred stock offering, net of issuance costs 57,785 0 0
Cash dividends paid on common stock (10,981) (10,358) (10,237)
Cash dividends paid on preferred stock (1,147) 0 0
Proceeds from long-term borrowings 231,985 30,353 50,000
Repayments on long-term borrowings (459,892) (47,563) (27,826)
Net change in short-term borrowings 0 0 (34,416)
Net Cash Provided By Financing Activities 479,642 464,105 418,038
Net Increase in Cash and Cash Equivalents 339,720 147,411 10,218
Cash and Cash Equivalents, Beginning 192,974 45,563 35,345
Cash and Cash Equivalents, Ending 532,694 192,974 45,563
Cash paid during the period for:      
Interest 32,957 39,282 26,551
Income taxes 9,524 8,006 7,050
Supplemental Noncash Disclosures:      
Transfers to other real estate owned 241 2,066 228
Grant of restricted stock awards from treasury stock 934 1,086 996
Grant of performance based restricted stock awards from treasury stock 217 21 0
Restricted stock forfeiture 0 71 11
Right of use assets obtained in exchange for lease liabilities $ 1,386 $ 19,465 $ 0